Annual CFO
-$296.06 M
+$13.42 M+4.34%
31 December 2023
Summary:
Agios Pharmaceuticals annual cash flow from operations is currently -$296.06 million, with the most recent change of +$13.42 million (+4.34%) on 31 December 2023. During the last 3 years, it has risen by +$111.26 million (+27.31%). AGIO annual CFO is now -867.76% below its all-time high of $38.56 million, reached on 31 December 2016.AGIO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$84.22 M
-$11.63 M-16.02%
30 September 2024
Summary:
Agios Pharmaceuticals quarterly cash flow from operations is currently -$84.22 million, with the most recent change of -$11.63 million (-16.02%) on 30 September 2024. Over the past year, it has dropped by -$11.73 million (-16.18%). AGIO quarterly CFO is now -153.36% below its all-time high of $157.82 million, reached on 30 June 2016.AGIO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$329.16 M
-$22.57 M-7.36%
30 September 2024
Summary:
Agios Pharmaceuticals TTM cash flow from operations is currently -$329.16 million, with the most recent change of -$22.57 million (-7.36%) on 30 September 2024. Over the past year, it has dropped by -$33.10 million (-11.18%). AGIO TTM CFO is now -494.34% below its all-time high of $83.47 million, reached on 30 June 2016.AGIO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGIO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -16.2% | -11.2% |
| 3 y3 years | +27.3% | -0.1% | +19.2% |
| 5 y5 years | +20.1% | +10.0% | +11.2% |
AGIO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.3% | -36.6% | +15.7% | -13.6% | +19.2% |
| 5 y | 5 years | -1.8% | +27.3% | -70.5% | +30.3% | -13.6% | +19.2% |
| alltime | all time | -867.8% | +27.3% | -153.4% | +30.3% | -494.3% | +19.2% |
Agios Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$84.22 M(+16.0%) | -$329.16 M(+7.4%) |
| June 2024 | - | -$72.59 M(-27.3%) | -$306.59 M(+1.9%) |
| Mar 2024 | - | -$99.87 M(+37.8%) | -$300.75 M(+1.6%) |
| Dec 2023 | -$296.06 M(-4.3%) | -$72.49 M(+17.6%) | -$296.06 M(+2.2%) |
| Sept 2023 | - | -$61.64 M(-7.6%) | -$289.74 M(-3.2%) |
| June 2023 | - | -$66.75 M(-29.9%) | -$299.44 M(-2.4%) |
| Mar 2023 | - | -$95.18 M(+43.9%) | -$306.93 M(-0.8%) |
| Dec 2022 | -$309.48 M(-24.0%) | -$66.16 M(-7.3%) | -$309.48 M(-5.5%) |
| Sept 2022 | - | -$71.35 M(-3.9%) | -$327.41 M(-4.1%) |
| June 2022 | - | -$74.23 M(-24.1%) | -$341.24 M(-11.2%) |
| Mar 2022 | - | -$97.73 M(+16.2%) | -$384.31 M(-5.7%) |
| Dec 2021 | -$407.32 M(+40.1%) | -$84.09 M(-1.3%) | -$407.32 M(+9.3%) |
| Sept 2021 | - | -$85.18 M(-27.4%) | -$372.62 M(+4.8%) |
| June 2021 | - | -$117.29 M(-2.9%) | -$355.65 M(+16.2%) |
| Mar 2021 | - | -$120.75 M(+144.4%) | -$306.15 M(+5.3%) |
| Dec 2020 | -$290.76 M(-21.5%) | -$49.40 M(-27.6%) | -$290.76 M(-13.2%) |
| Sept 2020 | - | -$68.21 M(+0.6%) | -$334.97 M(-4.9%) |
| June 2020 | - | -$67.80 M(-35.7%) | -$352.36 M(-5.5%) |
| Mar 2020 | - | -$105.36 M(+12.5%) | -$372.71 M(+0.6%) |
| Dec 2019 | -$370.62 M(+21.7%) | -$93.61 M(+9.4%) | -$370.62 M(+5.5%) |
| Sept 2019 | - | -$85.59 M(-2.9%) | -$351.20 M(+6.6%) |
| June 2019 | - | -$88.15 M(-14.6%) | -$329.45 M(+6.7%) |
| Mar 2019 | - | -$103.27 M(+39.2%) | -$308.69 M(+1.4%) |
| Dec 2018 | -$304.42 M | -$74.19 M(+16.2%) | -$304.42 M(-0.1%) |
| Sept 2018 | - | -$63.84 M(-5.3%) | -$304.69 M(-4.4%) |
| June 2018 | - | -$67.39 M(-31.9%) | -$318.56 M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$99.00 M(+33.0%) | -$310.16 M(+8.7%) |
| Dec 2017 | -$285.23 M(-839.7%) | -$74.45 M(-4.2%) | -$285.23 M(+8.9%) |
| Sept 2017 | - | -$77.72 M(+31.7%) | -$262.00 M(+12.3%) |
| June 2017 | - | -$58.99 M(-20.4%) | -$233.32 M(+1313.8%) |
| Mar 2017 | - | -$74.07 M(+44.6%) | -$16.50 M(-142.8%) |
| Dec 2016 | $38.56 M(-150.1%) | -$51.22 M(+4.5%) | $38.56 M(-34.9%) |
| Sept 2016 | - | -$49.03 M(-131.1%) | $59.26 M(-29.0%) |
| June 2016 | - | $157.82 M(-930.3%) | $83.47 M(-218.6%) |
| Mar 2016 | - | -$19.01 M(-37.7%) | -$70.37 M(-8.5%) |
| Dec 2015 | -$76.95 M(+29.6%) | -$30.53 M(+23.0%) | -$76.95 M(+42.0%) |
| Sept 2015 | - | -$24.82 M(-723.5%) | -$54.20 M(+2.6%) |
| June 2015 | - | $3.98 M(-115.6%) | -$52.85 M(-8.7%) |
| Mar 2015 | - | -$25.59 M(+229.1%) | -$57.90 M(-2.5%) |
| Dec 2014 | -$59.35 M(+5.2%) | -$7.78 M(-66.9%) | -$59.35 M(-9.0%) |
| Sept 2014 | - | -$23.47 M(+2091.1%) | -$65.19 M(+15.0%) |
| June 2014 | - | -$1.07 M(-96.0%) | -$56.71 M(-20.6%) |
| Mar 2014 | - | -$27.04 M(+98.6%) | -$71.46 M(+26.7%) |
| Dec 2013 | -$56.40 M(+13.8%) | -$13.62 M(-9.1%) | -$56.40 M(+3.7%) |
| Sept 2013 | - | -$14.98 M(-5.3%) | -$54.41 M(+7.0%) |
| June 2013 | - | -$15.82 M(+32.1%) | -$50.83 M(+11.6%) |
| Mar 2013 | - | -$11.98 M(+3.0%) | -$45.55 M(-8.1%) |
| Dec 2012 | -$49.55 M(+225.6%) | -$11.63 M(+2.0%) | -$49.55 M(+30.7%) |
| Sept 2012 | - | -$11.40 M(+8.1%) | -$37.92 M(+43.0%) |
| June 2012 | - | -$10.55 M(-34.0%) | -$26.52 M(+66.0%) |
| Mar 2012 | - | -$15.97 M | -$15.97 M |
| Dec 2011 | -$15.22 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFO year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFO year-on-year change?
What is Agios Pharmaceuticals annual cash flow from operations?
The current annual CFO of AGIO is -$296.06 M
What is the all time high annual CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from operations is $38.56 M
What is Agios Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of AGIO is -$84.22 M
What is the all time high quarterly CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from operations is $157.82 M
What is Agios Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, AGIO quarterly cash flow from operations has changed by -$11.73 M (-16.18%)
What is Agios Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of AGIO is -$329.16 M
What is the all time high TTM CFO for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from operations is $83.47 M
What is Agios Pharmaceuticals TTM CFO year-on-year change?
Over the past year, AGIO TTM cash flow from operations has changed by -$33.10 M (-11.18%)